BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 16157199)

  • 1. Leukemic recombinations involving heterochromatin in myeloproliferative disorders with t(1;9).
    Sambani C; La Starza R; Pierini V; Vandenberghe P; Gonzales-Aguilera JJ; Rigana H; Koumbi D; Manola KN; Stavropoulou C; Georgakakos VN; Pagoni M; Wlodarska I; Mecucci C
    Cancer Genet Cytogenet; 2005 Oct; 162(1):45-9. PubMed ID: 16157199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gain of 9p due to an unbalanced rearrangement der(9;18): a recurrent clonal abnormality in chronic myeloproliferative disorders.
    Bacher U; Haferlach T; Schoch C
    Cancer Genet Cytogenet; 2005 Jul; 160(2):179-83. PubMed ID: 15993276
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Numerical gain and structural rearrangements of JAK2, identified by FISH, characterize both JAK2617V>F-positive and -negative patients with Ph-negative MPD, myelodysplasia, and B-lymphoid neoplasms.
    Najfeld V; Cozza A; Berkofsy-Fessler W; Prchal J; Scalise A
    Exp Hematol; 2007 Nov; 35(11):1668-76. PubMed ID: 17976519
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of the recurrent translocation t(1;1)(p36.3;q21.1-2) in non-Hodgkin lymphoma by multicolor banding and fluorescence in situ hybridization analysis.
    Lestou VS; Ludkovski O; Connors JM; Gascoyne RD; Lam WL; Horsman DE
    Genes Chromosomes Cancer; 2003 Apr; 36(4):375-81. PubMed ID: 12619161
    [TBL] [Abstract][Full Text] [Related]  

  • 5. t(6;8), t(8;9) and t(8;13) translocations associated with stem cell myeloproliferative disorders have close or identical breakpoints in chromosome region 8p11-12.
    Chaffanet M; Popovici C; Leroux D; Jacrot M; Adélaïde J; Dastugue N; Grégoire MJ; Hagemeijer A; Lafage-Pochitaloff M; Birnbaum D; Pébusque MJ
    Oncogene; 1998 Feb; 16(7):945-9. PubMed ID: 9484786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Translocation (X;20) involving the inactive X chromosome in a patient with myeloproliferative disorder.
    O'Reilly J; Crawford J; Uzaraga J; Cannell P
    Cancer Genet Cytogenet; 2005 Apr; 158(1):81-3. PubMed ID: 15771910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Localization by FISH of centric fission breakpoints in a de novo trisomy 9p patient with i(9p) and t(9q;11p).
    Petit P; Devriendt K; Vermeesch JR; Meireleire J; Fryns JP
    Genet Couns; 1998; 9(3):215-21. PubMed ID: 9777345
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pattern of trisomy 1q in hematological malignancies: a single institution experience.
    Djordjević V; Dencić-Fekete M; Jovanović J; Drakulić D; Stevanović M; Janković G; Gotić M
    Cancer Genet Cytogenet; 2008 Oct; 186(1):12-8. PubMed ID: 18786437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant balanced and unbalanced translocations as a consequence of a balanced complex chromosomal rearrangement involving eight breakpoints in four chromosomes.
    Röthlisberger B; Kotzot D; Brecevic L; Koehler M; Balmer D; Binkert F; Schinzel A
    Eur J Hum Genet; 1999 Dec; 7(8):873-83. PubMed ID: 10602362
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cryptic translocations involving chromosome 20 in polycythemia vera.
    Busson M; Romana S; Nguyen Khac F; Bernard O; Berger R
    Ann Genet; 2004; 47(4):365-71. PubMed ID: 15581834
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Malignant peripheral nerve sheath tumor with rhabdomyoblastic differentiation (malignant triton tumor) with balanced t(7;9)(q11.2;p24) and unbalanced translocation der(16)t(1;16)(q23;q13).
    Velagaleti GV; Miettinen M; Gatalica Z
    Cancer Genet Cytogenet; 2004 Feb; 149(1):23-7. PubMed ID: 15104279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unique t(Y;1)(q12;q12) reciprocal translocation with loss of the heterochromatic region of chromosome 1 in a male with azoospermia due to meiotic arrest: a case report.
    Pinho MJ; Neves R; Costa P; Ferrás C; Sousa M; Alves C; Almeida C; Fernandes S; Silva J; Ferrás L; Barros A
    Hum Reprod; 2005 Mar; 20(3):689-96. PubMed ID: 15665019
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic and molecular aspects of Philadelphia negative chronic myeloproliferative disorders: clinical implications.
    Panani AD
    Cancer Lett; 2007 Sep; 255(1):12-25. PubMed ID: 17383090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosa-associated lymphoid tissue lymphoma: novel translocations including rearrangements of ODZ2, JMJD2C, and CNN3.
    Vinatzer U; Gollinger M; Müllauer L; Raderer M; Chott A; Streubel B
    Clin Cancer Res; 2008 Oct; 14(20):6426-31. PubMed ID: 18927281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extra translocation +der(1q9p) is a prognostic indicator in myeloproliferative disorders.
    Rege-Cambrin G; Speleman F; Kerim S; Scaravaglio P; Carozzi F; Dal Cin P; Michaux JL; Offner F; Saglio G; Van den Berghe H
    Leukemia; 1991 Dec; 5(12):1059-63. PubMed ID: 1774954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Confirmation of a novel recurrent association: BCR-ABL t(9;22) and t(19;21).
    Struski S; Hélias C; Gervais C; Leymarie V; Audhuy B; Moskovtchenko P; Lutz P; Gaub MP; Lessard M
    Cancer Genet Cytogenet; 2007 Dec; 179(2):127-31. PubMed ID: 18036399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derivative (1;18)(q10;q10): a recurrent and novel unbalanced translocation involving 1q in myeloid disorders.
    Wan TS; Ma SK; Au WY; Chan LC
    Cancer Genet Cytogenet; 2001 Jul; 128(1):35-8. PubMed ID: 11454427
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined trisomy 9P and Shprintzen syndrome resulting from a paternal t(9;22).
    Komatsu H; Kihara A; Komura E; Mitsufuji N; Tsujii H; Kakita S; Ikuta H
    Genet Couns; 2001; 12(2):137-43. PubMed ID: 11491308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A der(18)t(9;18)(p13;p11) and a der(9;18)(p10;q10) in polycythemia vera associated with a hyperproliferative phenotype in transformation to postpolycythemic myelofibrosis.
    Larsen TS; Hasselbalch HC; Pallisgaard N; Kerndrup GB
    Cancer Genet Cytogenet; 2007 Jan; 172(2):107-12. PubMed ID: 17213018
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chronic idiopathic myelofibrosis (CIMF) resulting from a unique 3;9 translocation disrupting the janus kinase 2 (JAK2) gene.
    Mark HF; Sotomayor EA; Nelson M; Chaves F; Sanger WG; Kaleem Z; Caughron SK
    Exp Mol Pathol; 2006 Dec; 81(3):217-23. PubMed ID: 16959246
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.